Mahalo Discussions

The Mahalo Health Platform combines our complete hybrid and Decentralized Clinical Trials (DCT) suite with digital health building blocks that accelerate digital health product development. With Mahalo, researchers, founders, and executives can create digital health products and collect clinical trial evidence on a single platform. Leverage Mahalo to study new Digital Therapeutics (DTx) or add our modules to your clinical trial that help you improve adherence, reduce drop-out rates, and identify adverse events. Whether you're running a site-based, hybrid, or fully-decentralized clinical trial, utilize the Mahalo platform to reduce your study's risks and costs. Mahalo has all the industry standard DCT features, including eSource, eCRF, eCOA, ePRO, eConsent, CTMS, and RTSM. The platform also integrates with most EHR/EMR systems and automatically pulls medical records into your EDC, reducing data entry time by research coordinators. By building the Mahalo Platform on a single code base, we reduce the time expensive database engineers spend checking the system during system validation. When users leave Mahalo reviews, G2 also collects common questions about the day-to-day use of Mahalo. These questions are then answered by our community of 850k professionals. Submit your question below and join in on the G2 Discussion.